WishBone Medical10.29.19
WishBone Medical has signed a global distribution agreement with Optimal, immediately spawning widespread distribution opportunities to reach children with orthopedic issues everywhere.
The commitment to provide global access to innovative, anatomically appropriate implants and instruments for children just became a reality. This distribution agreement will open access to thousands of channel partner sales associates and allow delivery of WishBone Medical’s single-use, sterile packed, complete procedure kits to surgeons that care for children in thousands of hospitals and ambulatory surgical centers anywhere in the world, next day.
Optimal’s Master Distribution program is partnered with all of the national distributors across the country and can reach virtually all surgeons in the pediatric orthopedics industry—a global market worth $2.5 billion according to the company. Additionally, Optimal’s Government Services program will provide direct access to Veteran Administration (VA) Medical Centers and Department of Defense (DoD) Military Treatment Facilities around the world, as well as Indian Health Service (IHS) Hospitals across the U.S.
“This is a huge day for surgeons who have not been able to gain access to pediatric orthopedic implants. The collaboration between WishBone Medical and Optimal creates a phenomenal network and outreach to the pediatric patient and their caregivers that has been needed for a long, long time,” said Nick Deeter, WishBone Medical’s founder and CEO.
Deeter continued, “Anatomically appropriate implants for children are limited to a small number of pediatric orthopedic hospitals because of the old distribution model of using reusable commodity instruments and implants, which leaves 95% of pediatric patients to be treated with FDA off-label implants. The WishBone Medical business model of sterile packed procedure kits, along with Optimal’s logistics capabilities, will bypass these obstacles and make it possible to help all kids with orthopedic issues.”
“I’ve been excited about the potential to work with WishBone Medical since first meeting with them. With this partnership, Optimal will have the immediate opportunity to enter the orthopedic market focused on children, thanks in large part to WishBone’s sterile packed procedure kits,” added Manny Losada, CEO and president of Optimal/MedPro Associates.
Kevin Blue, chief revenue officer for WishBone Medical, commented, “The combined collaboration, focus, and teamwork from two industry leading sales teams will allow us to maximize our efforts to help children around the world.”
The commitment to provide global access to innovative, anatomically appropriate implants and instruments for children just became a reality. This distribution agreement will open access to thousands of channel partner sales associates and allow delivery of WishBone Medical’s single-use, sterile packed, complete procedure kits to surgeons that care for children in thousands of hospitals and ambulatory surgical centers anywhere in the world, next day.
Optimal’s Master Distribution program is partnered with all of the national distributors across the country and can reach virtually all surgeons in the pediatric orthopedics industry—a global market worth $2.5 billion according to the company. Additionally, Optimal’s Government Services program will provide direct access to Veteran Administration (VA) Medical Centers and Department of Defense (DoD) Military Treatment Facilities around the world, as well as Indian Health Service (IHS) Hospitals across the U.S.
“This is a huge day for surgeons who have not been able to gain access to pediatric orthopedic implants. The collaboration between WishBone Medical and Optimal creates a phenomenal network and outreach to the pediatric patient and their caregivers that has been needed for a long, long time,” said Nick Deeter, WishBone Medical’s founder and CEO.
Deeter continued, “Anatomically appropriate implants for children are limited to a small number of pediatric orthopedic hospitals because of the old distribution model of using reusable commodity instruments and implants, which leaves 95% of pediatric patients to be treated with FDA off-label implants. The WishBone Medical business model of sterile packed procedure kits, along with Optimal’s logistics capabilities, will bypass these obstacles and make it possible to help all kids with orthopedic issues.”
“I’ve been excited about the potential to work with WishBone Medical since first meeting with them. With this partnership, Optimal will have the immediate opportunity to enter the orthopedic market focused on children, thanks in large part to WishBone’s sterile packed procedure kits,” added Manny Losada, CEO and president of Optimal/MedPro Associates.
Kevin Blue, chief revenue officer for WishBone Medical, commented, “The combined collaboration, focus, and teamwork from two industry leading sales teams will allow us to maximize our efforts to help children around the world.”